FR1459417A - Procédé pour la préparation de dérivés de pyrimidine - Google Patents

Procédé pour la préparation de dérivés de pyrimidine

Info

Publication number
FR1459417A
FR1459417A FR37175A FR37175A FR1459417A FR 1459417 A FR1459417 A FR 1459417A FR 37175 A FR37175 A FR 37175A FR 37175 A FR37175 A FR 37175A FR 1459417 A FR1459417 A FR 1459417A
Authority
FR
France
Prior art keywords
preparation
pyrimidine derivatives
pyrimidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR37175A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US470917A external-priority patent/US3341541A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Priority to FR37175A priority Critical patent/FR1459417A/fr
Application granted granted Critical
Publication of FR1459417A publication Critical patent/FR1459417A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
FR37175A 1964-11-12 1965-11-04 Procédé pour la préparation de dérivés de pyrimidine Expired FR1459417A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR37175A FR1459417A (fr) 1964-11-12 1965-11-04 Procédé pour la préparation de dérivés de pyrimidine

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US41071064A 1964-11-12 1964-11-12
US41079364A 1964-11-12 1964-11-12
US45417265A 1965-05-07 1965-05-07
US45416865A 1965-05-07 1965-05-07
US46083465A 1965-06-02 1965-06-02
US470917A US3341541A (en) 1964-11-12 1965-07-09 Processes and intermediates for pyrimidine derivatives
FR37175A FR1459417A (fr) 1964-11-12 1965-11-04 Procédé pour la préparation de dérivés de pyrimidine

Publications (1)

Publication Number Publication Date
FR1459417A true FR1459417A (fr) 1966-04-29

Family

ID=27562272

Family Applications (1)

Application Number Title Priority Date Filing Date
FR37175A Expired FR1459417A (fr) 1964-11-12 1965-11-04 Procédé pour la préparation de dérivés de pyrimidine

Country Status (1)

Country Link
FR (1) FR1459417A (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2133752A1 (fr) * 1971-04-16 1972-12-01 Wellcome Found
FR2183769A1 (fr) * 1972-05-08 1973-12-21 Pliva Pharm & Chem Works
FR2283129A1 (fr) * 1974-03-01 1976-03-26 Wellcome Found Procede de preparation d'un derive de pyrimidine et nouveau produit ainsi obtenu

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2133752A1 (fr) * 1971-04-16 1972-12-01 Wellcome Found
FR2183769A1 (fr) * 1972-05-08 1973-12-21 Pliva Pharm & Chem Works
FR2283129A1 (fr) * 1974-03-01 1976-03-26 Wellcome Found Procede de preparation d'un derive de pyrimidine et nouveau produit ainsi obtenu

Similar Documents

Publication Publication Date Title
FR1455059A (fr) Procédé pour la préparation de dérivés de benzodiazépine
FR1522686A (fr) Procédé pour la préparation de dérivés de pyridindole
CH473130A (fr) Procédé pour la préparation de dérivés de la quinazoline
FR1428086A (fr) Procédé pour la préparation de dérivés de dibenzocycloheptatriène
FR1439925A (fr) Procédé pour la préparation de dérivés cyclopenténoniques
CH485741A (fr) Procédé de préparation de dérivés de benzodiazépines
FR1459013A (fr) Procédé de préparation de dérivés de la 4-phényl-pipéridine
FR1470809A (fr) Procédé pour la préparation de dérivés de nu-acyl-vinylamines
CH470393A (fr) Procédé de préparation de dérivés de la berbine
FR1459759A (fr) Procédé pour la préparation de dérivés de quinazoline
FR1453056A (fr) Procédé pour la préparation de dérivés de pyrimidine
CH445504A (fr) Procédé pour la préparation de dérivés de la triazolone
FR1459417A (fr) Procédé pour la préparation de dérivés de pyrimidine
FR1455434A (fr) Procédé pour la préparation de dérivés de propiophénone
FR1428671A (fr) Procédé pour la préparation de dérivés de phénanthrène
FR1405699A (fr) Procédé pour la préparation de dérivés de benzodiazépine
FR1447040A (fr) Procédé pour la préparation de dérivés de benzodiazépine
FR1463319A (fr) Procédé pour la préparation de dérivés de dihydrodibenzocycloheptène
FR1464312A (fr) Procédé pour la préparation de dérivés de dihydrodibenzocycloheptène
FR1395924A (fr) Procédé pour la préparation de dérivés de quinazolone
FR1518635A (fr) Procédé de préparation de dérivés de la pyrimidine
FR1456796A (fr) Procédé pour la préparation de dérivés de gamma-picolyle
FR1451254A (fr) Procédé pour la préparation de dérivés de dibenzocycloheptatriène
FR1479266A (fr) Procédé pour la préparation de dérivés de phénanthrène
FR1425603A (fr) Procédé de préparation de dérivés de la purine